CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection
- PMID: 23165450
- PMCID: PMC7086553
- DOI: 10.1038/pr.2012.163
CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection
Abstract
Background: Current tools to predict the severity of respiratory syncytial virus (RSV) infection might be improved by including immunological parameters. We hypothesized that a combination of inflammatory markers would differentiate between severe and mild disease in RSV-infected children.
Methods: Blood and nasopharyngeal samples from 52 RSV-infected children were collected during acute infection and after recovery. Retrospectively, patients were categorized into three groups based on disease severity: mild (no supportive treatment), moderate (supplemental oxygen and/or nasogastric feeding), and severe (mechanical ventilation). Clinical data, number of flow-defined leukocyte subsets, and cytokine concentrations were compared.
Results: Children with severe RSV infection were characterized by young age; lymphocytopenia; increased interleukin (IL)-8, granulocyte colony-stimulating factor (G-CSF), and IL-6 concentrations; and decreased chemokine (C-C motif) ligand (CCL-5) concentrations in plasma. The combination of plasma levels of IL-8 and CCL-5, and CD4+ T-cell counts, with cutoff values of 67 pg/ml, 13 ng/ml, and 2.3 × 10(6)/ml, respectively, discriminated severe from mild RSV infection with 82% sensitivity and 96% specificity.
Conclusion: This study demonstrates that the combination of CD4+ T-cell counts and IL-8 and CCL-5 plasma concentrations correlates with disease severity in RSV-infected children. In addition to clinical features, these immunological markers may be used to assess severity of RSV infection and guide clinical management.
Figures
Similar articles
-
T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.Pediatrics. 2006 May;117(5):e878-86. doi: 10.1542/peds.2005-2119. Epub 2006 Apr 17. Pediatrics. 2006. PMID: 16618789
-
Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis.Eur Respir J. 1999 Jul;14(1):144-9. doi: 10.1034/j.1399-3003.1999.14a24.x. Eur Respir J. 1999. PMID: 10489842 Clinical Trial.
-
Respiratory Syncytial Virus (RSV) Infects CD4+ T Cells: Frequency of Circulating CD4+ RSV+ T Cells as a Marker of Disease Severity in Young Children.J Infect Dis. 2017 Apr 1;215(7):1049-1058. doi: 10.1093/infdis/jix070. J Infect Dis. 2017. PMID: 28199704 Free PMC article.
-
Immunological and Inflammatory Biomarkers of Susceptibility and Severity in Adult Respiratory Syncytial Virus Infections.J Infect Dis. 2020 Oct 7;222(Suppl 7):S584-S591. doi: 10.1093/infdis/jiaa063. J Infect Dis. 2020. PMID: 32227102 Review.
-
Immunological mechanisms of severe respiratory syncytial virus bronchiolitis.Intensive Care Med. 2002 May;28(5):616-21. doi: 10.1007/s00134-002-1256-z. Epub 2002 Mar 26. Intensive Care Med. 2002. PMID: 12029411 Review.
Cited by
-
Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function.J Infect Dis. 2019 Feb 15;219(5):723-733. doi: 10.1093/infdis/jiy566. J Infect Dis. 2019. PMID: 30252097 Free PMC article.
-
Identification of biomarkers for disease severity in nasopharyngeal secretions of infants with upper or lower respiratory tract viral infections.Clin Exp Immunol. 2022 Oct 21;210(1):68-78. doi: 10.1093/cei/uxac083. Clin Exp Immunol. 2022. PMID: 36036806 Free PMC article.
-
Cilia-related gene signature in the nasal mucosa correlates with disease severity and outcomes in critical respiratory syncytial virus bronchiolitis.Front Immunol. 2022 Sep 23;13:924792. doi: 10.3389/fimmu.2022.924792. eCollection 2022. Front Immunol. 2022. PMID: 36211387 Free PMC article.
-
Long-Term Infection and Pathogenesis in a Novel Mouse Model of Human Respiratory Syncytial Virus.Viruses. 2022 Aug 9;14(8):1740. doi: 10.3390/v14081740. Viruses. 2022. PMID: 36016362 Free PMC article.
-
Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.Rev Med Virol. 2014 Jan;24(1):55-70. doi: 10.1002/rmv.1773. Epub 2013 Nov 14. Rev Med Virol. 2014. PMID: 24227634 Free PMC article. Review.
References
-
- Black CP. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care. 2003;48:209–31; discussion 231–3. - PubMed
-
- Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol. 2005;16:386–92. doi: 10.1111/j.1399-3038.2005.00298.x. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials